3-氟吡啶-2-羧酸甲酯 | 869108-35-0

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 3-氟吡啶-2-羧酸甲酯
• 中文别名: 3-氟吡啶-2-甲酸甲酯
• 英文名称: methyl 3-fluoropyridine-2-carboxylate
• 英文别名: methyl 3-fluoropicolinate
• CAS: 869108-35-0
• 化学式: C₇H₆FNO₂
• mdl: MFCD06659496
• 分子量: 155.129
• InChiKey: CZBVTGOJEKVWBB-UHFFFAOYSA-N

物化性质

• 沸点：
  228.8±25.0 °C(Predicted)
• 密度：
  1.243±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-fluoropicolinate
Synonyms: Methyl 3-fluoropyridine-2-carboxylate

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-fluoropicolinate
CAS number: 869108-35-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6FNO2
Molecular weight: 155.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氟吡啶-2-羧酸甲酯 在 硼氘化钠 作用下， 以 乙醇 为溶剂， 反应 2.0h， 生成 (3-fluoropyridin-2-yl)methan-d2-ol
  参考文献：
  名称：

  [EN] COMPOUNDS USEFUL AS FACTOR XIA INHIBITORS
  [FR] COMPOSÉS UTILES EN TANT QU'INHIBITEURS DU FACTEUR XIA

  摘要：

  本发明涉及因子XIa抑制剂、互变异构体、立体异构体、同位素拓扑异构体及其药学上可接受的盐和溶剂合物，包含上述化合物的制药组合物以及在治疗和/或预防血栓栓塞性疾病、炎症性疾病以及涉及血浆激肽酶活性的疾病或病况中使用上述化合物的用途。

  公开号：

  WO2022018156A1
• 作为产物：
  描述：

  3-氟吡啶 在 正丁基锂 、 potassium carbonate 作用下， 以 四氢呋喃 、 正己烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 3-氟吡啶-2-羧酸甲酯
  参考文献：
  名称：

  The discovery of potent small molecule cyclic urea activators of STING

  摘要：

  DOI：

  10.1016/j.ejmech.2021.114087

文献信息

• [EN] 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS<br/>[FR] DÉRIVÉS DE 5,6,7,8-TÉTRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZINE COMME MODULATEURS DE P2X7
  申请人：GLAXO GROUP LTD

  公开号：WO2010125102A1

  公开（公告）日：2010-11-04

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2fluoroalkyl, halogen, NR6 R7, optionally substituted heteroaryl (Het), or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis, osteoarthritis or neurodegenerative disorders.

  本发明提供了一种式(I)化合物或其药学上可接受的盐，其中A为氢、C1-4烷基、C3-6环烷基、C1-3烷氧基、C1-3烷氧基C1-4烷基、C1-2氟烷基、卤素、NR6 R7、任选取代的杂芳基(Het)或任选取代的苯基，且R1、R2、R3、R4、R5、R6和R7如说明书中所定义。这些化合物或盐被认为能够调节P2X7受体功能，并能拮抗ATP在P2X7受体上的作用。本发明还提供了该化合物或盐在治疗或预防例如炎症性疼痛、神经性疼痛、内脏疼痛、类风湿性关节炎、骨关节炎或神经退行性疾病中的用途。
• METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME
  申请人：Suh Dong-Hack

  公开号：US20090306395A1

  公开（公告）日：2009-12-10

  The present invention relates to a light emitting transition metal compound of Chemical Formula 1 and an organic electroluminescence device including the compound. In the Chemical Formula 1, M is selected from Ir, Pt, Rh, Re, and Os, m is 2 or 3, n is 0 or 1, the sum of m and n is 3, provided that the sum of m and n is 2 M is Pt. X is a N or P atom, and Y is S, O, or Se.

  本发明涉及化学式1的发光过渡金属化合物以及包括该化合物的有机电致发光器件。 在化学式1中，M从Ir、Pt、Rh、Re和Os中选择，m为2或3，n为0或1，m和n的和为3，前提是m和n的和为2时M为Pt。X是N或P原子，Y是S、O或Se。
• Metallic Compound and Organic Electroluminescence Device Comprising the Same
  申请人：Suh Dong-Hack

  公开号：US20080200678A1

  公开（公告）日：2008-08-21

  The present invention relates to a light-emitting transition metal compound represented by the Chemical Formula 1 and Chemical Formula 2 and an organic electroluminescence device including the same. In the Chemical Formulae 1 and 2, M is Ir, Pt, Rh, Re, Os, and the like, m is 2 or 3, n is 0 or 1, the sum of m and n is 3, provided that the sum of m and n is 2 when M is Pt, X, and Z are the same or different, N or P, and Y and Q are O, S, or Se, R 1 and R 5 are hydrogen, a C1 to C20 alkyl excluding an aromatic cyclic substituent, a cycloalkyl, a halogen, a linear or branched substituent including at least one halogen, or a linear or branched substituent including at least one heteroatom, and R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 9 , and R 10 are hydrogen, a C1 to C20 alkyl, an aryl, a cycloalkyl, a halogen, a linear or branched substituent including at least one halogen, a linear or branched substituent including at least one heteroatom, carbonyl, vinyl, or acetylenyl, or may form a cycle, and may be the same or different.

  本发明涉及一种由化学式1和化学式2表示的发光过渡金属化合物，以及包括该化合物的有机电致发光器件。在化学式1和2中，M为Ir、Pt、Rh、Re、Os等，m为2或3，n为0或1，m和n的总和为3，当M为Pt时，m和n的总和为2，X和Z相同或不同，为N或P，Y和Q为O、S或Se，R1和R5为氢、除芳香环取代基外的C1到C20烷基、环烷基、卤素、线性或支链取代基，包括至少一个卤素，或包括至少一个杂原子的线性或支链取代基，R2、R3、R4、R6、R7、R8、R9和R10为氢、C1到C20烷基、芳基、环烷基、卤素、线性或支链取代基，包括至少一个卤素，线性或支链取代基，包括至少一个杂原子，羰基、烯基或乙炔基，或可形成环，并且可以相同或不同。
• [EN] COMPOUNDS AND METHOD FOR TREATMENT OF HIV<br/>[FR] COMPOSÉS ET MÉTHODES POUR LE TRAITEMENT DU VIH
  申请人：CRITICAL OUTCOME TECHNOLOGIES INC

  公开号：WO2011120153A1

  公开（公告）日：2011-10-06

  The invention relates to a compound of Formulae I and/or II: Formula I Formula II and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N-OH, NH, NO2, CN, N-CN, N=O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.

  该发明涉及公式I和/或II的化合物： 公式I 公式II 和/或药用可接受的盐、水合物、溶剂合物、互变异构体、光学异构体、E-异构体、Z-异构体或其组合； X选择自Se、N-OH、NH、NO2、CN、N-CN、N=O、O或S，其余取代基在此处描述；以及其组合物。 该发明还涉及其给药方法；以及用于治疗HIV的用途。
• 一种杂芳环类化合物及其用途
  申请人：南京奥利墨斯医药科技有限公司

  公开号：CN113072564A

  公开（公告）日：2021-07-06

  本发明涉及一种杂芳环类化合物及其用途。具体地，本发明提供一种式I化合物、或其光学异构体或其外消旋体、或其药学上可接受的盐。本发明所述的化合物能够显著增强抗生素的抗菌效果，从而降低抗生素的使用剂量和降低细菌耐药性的产生。